Suchergebnisse - "Yamada, Takahiro"

PubPharm (592)

1

Difficulties in disclosing secondary findings by facilities performing comprehensive germline genetic testing for rare diseases in Japan

enthalten in: Congenital anomalies | 2024

von Hiromoto, K. | Yamada, T. | Tsuchiya, M. | +4

2

Metabolic Tug-of-War between Glycolysis and Translation Revealed by Biochemical Reconstitution

enthalten in: ACS synthetic biology | 2024

von Sato, G. | Kinoshita, S. | Yamada, T. | +5

3

Manual on the proper use of the 211At-labeled PSMA ligand ([211At]PSMA-5) for clinical trials of targeted alpha therapy (1st edition)

enthalten in: Annals of nuclear medicine | 2024

von Watabe, T. | Namba, M. | Yanagida, S. | +9

4

Correction : 2-cyanopyridine derivatives enable N-terminal cysteine bioconjugation and peptide bond cleavage of glutathione under aqueous and mild conditions

enthalten in: RSC advances | 2024

von Yano, T. | Yamada, T. | Ishida, H. | +2

ErratumFor: RSC Adv. 2024 Feb 22;14(10):6542-6547. - PMID 38390509

5

Identification of a novel LFNG variant in a Chinese fetus with spondylocostal dysostosis and a systematic review

enthalten in: Journal of human genetics | 2024

von Wang, L. | Mizumoto, S. | Zhang, R. | +23

6

Comparing Three Different Anti-Programmed Death-Ligand 1 Antibodies in Immunohistochemical Evaluation of Combined Chemoimmunotherapy Response in Patients With NSCLC : A Prospective Study

enthalten in: JTO clinical and research reports | 2024

von Katayama, Y. | Yamada, T. | Morimoto, K. | +17

7

Manual on the proper use of the 211At-labeled PSMA ligand ([211At]PSMA-5) for clinical trials of targeted alpha therapy (1st edition)

enthalten in: Annals of nuclear medicine | 2024

von Watabe, T. | Namba, M. | Yanagida, S. | +9

8

Follicular dendritic cell sarcoma arising from the lymph node of the pancreatic head : a case report with literature review

enthalten in: Clinical journal of gastroenterology | 2024

von Yamada, T. | Ishido, K. | Kimura, N. | +7

9

Efficacy and Safety of Docetaxel plus Ramucirumab for Patients with Pretreated Advanced or Recurrent Non-small Cell Lung Cancer : Focus on Older Patients

enthalten in: Targeted oncology | 2024

von Onoi, K. | Yamada, T. | Morimoto, K. | +14

10

Dyssegmental dysplasia Rolland-Desbuquois type is caused by pathogenic variants in HSPG2 - a founder haplotype shared in five patients

enthalten in: Journal of human genetics | 2024

von Farshadyeganeh, P. | Yamada, T. | Ohashi, H. | +11

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[60]